|
CKS1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.092500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.641200E-01 |
| Normal-vs-Stage2 |
7.071800E-01 |
| Normal-vs-Stage3 |
2.137300E-03 |
| Normal-vs-Stage4 |
1.412110E-02 |
| Stage1-vs-Stage2 |
9.165200E-01 |
| Stage1-vs-Stage3 |
8.205300E-04 |
| Stage1-vs-Stage4 |
3.343000E-03 |
| Stage2-vs-Stage3 |
4.158000E-02 |
| Stage2-vs-Stage4 |
3.452100E-02 |
| Stage3-vs-Stage4 |
5.939200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.121700E-02 |
| Normal-vs-AfricanAmerican |
1.828030E-01 |
| Normal-vs-Asian |
4.309000E-01 |
| Caucasian-vs-AfricanAmerican |
8.343200E-01 |
| Caucasian-vs-Asian |
6.461200E-01 |
| AfricanAmerican-vs-Asian |
5.365400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.496400E-01 |
| Normal-vs-Female |
2.055700E-03 |
| Male-vs-Female |
3.699000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.420500E-02 |
| Normal-vs-Extreme_Weight |
8.539200E-01 |
| Normal-vs-Obese |
1.051560E-02 |
| Normal-vs-Extreme_Obese |
2.126100E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.423700E-02 |
| Normal_Weight-vs-Obese |
7.713000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.786200E-04 |
| Extreme_Weight-vs-Obese |
1.052380E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.338300E-02 |
| Obese-vs-Extreme_Obese |
9.85009999999731E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.315900E-02 |
| Normal-vs-Age(41-60Yrs) |
8.732500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.772800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.013200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.670400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.646000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.091900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.347200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.394830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.954200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.387200E-01 |
| Normal-VS-Type2 PRCC |
2.853500E-02 |
| Normal-VS-KIRP CIMP |
1.117780E-03 |
| Normal-VS-Unclassified PRCC |
6.645800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.454270E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.036530E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.458400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.72284999999661E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.151200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.198750E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.946200E-01 |
| Normal-vs-N1 |
1.590320E-04 |
| Normal-vs-N2 |
1.297810E-01 |
| N0-vs-N1 |
3.961600E-04 |
| N0-vs-N2 |
1.454020E-02 |
| N1-vs-N2 |
9.270000E-01 |
|
|
